Personalis Total Assets 2018-2024 | PSNL

Personalis total assets from 2018 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Personalis Annual Total Assets
(Millions of US $)
2023 $225
2022 $293
2021 $397
2020 $245
2019 $157
2018 $42
2017 $0
Personalis Quarterly Total Assets
(Millions of US $)
2024-06-30 $186
2024-03-31 $195
2023-12-31 $225
2023-09-30 $227
2023-06-30 $249
2023-03-31 $272
2022-12-31 $293
2022-09-30 $318
2022-06-30 $358
2022-03-31 $381
2021-12-31 $397
2021-09-30 $407
2021-06-30 $383
2021-03-31 $396
2020-12-31 $245
2020-09-30 $249
2020-06-30 $146
2020-03-31 $152
2019-12-31 $157
2019-09-30 $160
2019-06-30 $192
2019-03-31 $0
2018-12-31 $0
2018-09-30 $0
2018-06-30 $0
2017-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.270B $0.073B
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Bausch Health Cos (BHC) Canada $3.597B 2.61
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00